Cargando…

Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations

Objective: The latest nonnucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine (RPV) is indicated for human immunodeficiency virus type-1 (HIV-1) patients initiating antiretroviral treatment, but the extent of genotypic RPV resistance in treatment-naive patients outside clinical trials is p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theys, Kristof, Van Laethem, Kristel, Gomes, Perpetua, Baele, Guy, Pineda-Peña, Andrea-Clemencia, Vandamme, Anne-Mieke, Camacho, Ricardo J., Abecasis, Ana B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845676/ https://www.ncbi.nlm.nih.gov/pubmed/26651266 http://dx.doi.org/10.1089/aid.2015.0095

Ejemplares similares

Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
por: Winand, Raf, et al.
Publicado: (2015)

Zika genomics urgently need standardized and curated reference sequences
por: Theys, Kristof, et al.
Publicado: (2017)

HIV-1 Gag C-terminal amino acid substitutions emerging under selective pressure of protease inhibitors in patient populations infected with different HIV-1 subtypes
por: Li, Guangdi, et al.
Publicado: (2014)

Advances in Visualization Tools for Phylogenomic and Phylodynamic Studies of Viral Diseases
por: Theys, Kristof, et al.
Publicado: (2019)

Drivers of HIV-1 transmission: The Portuguese case
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2019)

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations
por: Pingarilho, Marta, et al.
Publicado: (2020)

Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development
por: Cuypers, Lize, et al.
Publicado: (2016)

CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba
por: Kouri, Vivian, et al.
Publicado: (2015)

A new ensemble coevolution system for detecting HIV-1 protein coevolution
por: Li, Guangdi, et al.
Publicado: (2015)

Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing
por: Vrancken, Bram, et al.
Publicado: (2016)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

An integrated map of HIV genome-wide variation from a population perspective
por: Li, Guangdi, et al.
Publicado: (2015)

Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017
por: Pimentel, Victor, et al.
Publicado: (2020)

HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2018)

PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context
por: Libin, Pieter, et al.
Publicado: (2017)

The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates
por: Vrancken, Bram, et al.
Publicado: (2014)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen, Opass, et al.
Publicado: (2013)

HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments
por: Ho, Yung Shwen, et al.
Publicado: (2008)

Tracing the Impact of Public Health Interventions on HIV-1 Transmission in Portugal Using Molecular Epidemiology
por: Vasylyeva, Tetyana I, et al.
Publicado: (2019)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
por: Capina, Rupert, et al.
Publicado: (2020)

Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
por: Cuypers, Lize, et al.
Publicado: (2015)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia
por: Taramasso, Lucia, et al.
Publicado: (2019)

Functional conservation of HIV-1 Gag: implications for rational drug design
por: Li, Guangdi, et al.
Publicado: (2013)

Sharpness of Spike Initiation in Neurons Explained by Compartmentalization
por: Brette, Romain
Publicado: (2013)

Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland
por: Parczewski, Miłosz, et al.
Publicado: (2014)

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
por: Abecasis, Ana B, et al.
Publicado: (2013)

Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users
por: Paraschiv, Simona, et al.
Publicado: (2017)

The role of rilpivirine in Southern Africa
por: Moorhouse, Michelle A., et al.
Publicado: (2019)

Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries
por: Steegen, Kim, et al.
Publicado: (2023)

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal
por: Vercauteren, Jurgen, et al.
Publicado: (2008)

Gynoid Fat Distribution and Adipocyte Trapping May Explain Virological Failure With Intramuscular Long-Acting Cabotegravir and Rilpivirine
por: de Malliard, Isabelle, et al.
Publicado: (2023)

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy
por: Cuypers, Lize, et al.
Publicado: (2017)

Biochemical mechanism of clinical resistance to rilpivirine
por: Singh, Kamalendra, et al.
Publicado: (2012)

The development of an effective synthetic route of rilpivirine
por: Zhang, Tao, et al.
Publicado: (2021)

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
por: Theys, Kristof, et al.
Publicado: (2012)

Genome-wide diversity of Zika virus: Exploring spatio-temporal dynamics to guide a new nomenclature proposal
por: Seabra, Sofia G, et al.
Publicado: (2022)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
por: Ho, Sharlene, et al.
Publicado: (2020)

VIRULIGN: fast codon-correct alignment and annotation of viral genomes
por: Libin, Pieter J K, et al.
Publicado: (2019)

New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
por: Patel, Nimish, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_72lnpv73pl91smsr4t2e2jj0cl